Αποτελέσματα Αναζήτησης
25 Νοε 2019 · FRANKFURT/LONDON (Reuters) - European private equity firm CapVest has tapped potential bidders for its French nuclear medicine provider Curium, sources told Reuters, aiming for a deal that values...
9 Ιαν 2020 · CVC Capital Partners, Bain Capital, Clayton Dubilier & Rice, Nordic Capital and PAI Partners have submitted first-round bids to acquire Curium Pharma from CapVest in a deal that would value the company at $3 billion or more, according to Bloomberg.
1 Ιαν 2021 · Information on valuation, funding, acquisitions, investors, and executives for Curium Pharma (Paris). Use the PitchBook Platform to explore the full profile.
20 Οκτ 2020 · Intermediate Capital Group (ICG) is indirectly acquiring over 25% of the shares of Europe's largest radiopharmaceuticals provider Curium Pharma, HBI can reveal, after owner Capvest earlier pulled a majority sales process because of COVID-19.
Owner. Director, Executive Human Resources, Management, Medical & Science. 3 emails found 1 phone number found. View contacts for Curium Pharma to access new leads and connect with decision-makers. View All Contacts. Details. Industries. Pharmaceutical. Headquarters Regions European Union (EU), Europe, Middle East, and Africa (EMEA)
See Curium funding rounds, investors, investments, exits and more. Evaluate their financials based on Curium's post-money valuation and revenue.
Curium is a global leader in the field of nuclear medicine. The company's primary offerings include the development, manufacturing, and distribution of radiopharmaceutical products, which are used in the diagnosis and treatment of various diseases.
